 Vijayalakshmi Karoor
Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neprilysin | 4 | 2017 | 47 | 1.330 |
Why?
| | rho GTP-Binding Proteins | 2 | 2020 | 62 | 1.250 |
Why?
| | Muscle, Smooth, Vascular | 6 | 2017 | 420 | 1.120 |
Why?
| | Hypoxia | 8 | 2023 | 937 | 1.040 |
Why?
| | Hypertension, Pulmonary | 11 | 2021 | 1754 | 0.940 |
Why?
| | Pulmonary Artery | 13 | 2020 | 1037 | 0.920 |
Why?
| | Vascular Remodeling | 3 | 2021 | 155 | 0.880 |
Why?
| | rhoA GTP-Binding Protein | 4 | 2019 | 75 | 0.870 |
Why?
| | rho-Associated Kinases | 5 | 2019 | 81 | 0.860 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 2 | 2012 | 88 | 0.750 |
Why?
| | Butyrates | 1 | 2021 | 53 | 0.750 |
Why?
| | Metabolic Diseases | 1 | 2021 | 99 | 0.720 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2021 | 192 | 0.690 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2019 | 239 | 0.660 |
Why?
| | Cellular Microenvironment | 1 | 2019 | 78 | 0.640 |
Why?
| | Metabolome | 1 | 2021 | 287 | 0.640 |
Why?
| | Pneumonia | 2 | 2021 | 576 | 0.590 |
Why?
| | Endothelial Cells | 6 | 2023 | 696 | 0.550 |
Why?
| | Vascular Diseases | 1 | 2019 | 230 | 0.540 |
Why?
| | Myocardium | 3 | 2019 | 926 | 0.540 |
Why?
| | Muscle Proteins | 1 | 2017 | 209 | 0.530 |
Why?
| | Quinazolines | 3 | 2012 | 241 | 0.490 |
Why?
| | Vasa Vasorum | 3 | 2020 | 33 | 0.480 |
Why?
| | Carcinogens | 2 | 2012 | 105 | 0.480 |
Why?
| | Lung | 6 | 2021 | 3673 | 0.470 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 847 | 0.440 |
Why?
| | Cardiovascular Diseases | 2 | 2021 | 1729 | 0.440 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2013 | 24 | 0.430 |
Why?
| | Animals | 30 | 2023 | 32104 | 0.430 |
Why?
| | Piperidines | 2 | 2012 | 163 | 0.420 |
Why?
| | Neovascularization, Pathologic | 4 | 2020 | 283 | 0.370 |
Why?
| | Lung Neoplasms | 3 | 2012 | 2207 | 0.350 |
Why?
| | Pulmonary Alveoli | 2 | 2012 | 376 | 0.350 |
Why?
| | Aging | 1 | 2020 | 1632 | 0.350 |
Why?
| | ErbB Receptors | 2 | 2012 | 557 | 0.340 |
Why?
| | Signal Transduction | 9 | 2020 | 4541 | 0.330 |
Why?
| | Hemoglobins | 3 | 2021 | 312 | 0.310 |
Why?
| | Anemia, Sickle Cell | 2 | 2021 | 217 | 0.290 |
Why?
| | Heart Failure | 1 | 2019 | 1964 | 0.280 |
Why?
| | Proto-Oncogene Proteins c-myc | 2 | 2020 | 114 | 0.260 |
Why?
| | Mice, Knockout | 6 | 2023 | 2604 | 0.260 |
Why?
| | Propranolol | 1 | 2004 | 53 | 0.230 |
Why?
| | Receptors, Purinergic P2Y | 2 | 2020 | 7 | 0.230 |
Why?
| | Rats | 10 | 2021 | 5033 | 0.230 |
Why?
| | Enzyme Activation | 5 | 2017 | 793 | 0.220 |
Why?
| | Macrophages | 2 | 2021 | 1284 | 0.220 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2020 | 131 | 0.220 |
Why?
| | Up-Regulation | 2 | 2021 | 820 | 0.210 |
Why?
| | Mice | 12 | 2023 | 15052 | 0.210 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2021 | 142 | 0.200 |
Why?
| | Endothelin-1 | 2 | 2017 | 167 | 0.200 |
Why?
| | Sleep Apnea Syndromes | 2 | 2013 | 74 | 0.200 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2004 | 294 | 0.200 |
Why?
| | Rats, Sprague-Dawley | 5 | 2021 | 2262 | 0.200 |
Why?
| | Hemopexin | 1 | 2021 | 13 | 0.190 |
Why?
| | Urethane | 2 | 2012 | 41 | 0.190 |
Why?
| | Systole | 1 | 2021 | 174 | 0.190 |
Why?
| | Tight Junctions | 1 | 2021 | 68 | 0.190 |
Why?
| | Microvessels | 1 | 2021 | 68 | 0.190 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2023 | 342 | 0.190 |
Why?
| | Acetylation | 1 | 2021 | 212 | 0.190 |
Why?
| | Cytokines | 3 | 2021 | 1853 | 0.180 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 2 | 2020 | 146 | 0.180 |
Why?
| | Blood Pressure | 4 | 2021 | 1539 | 0.180 |
Why?
| | GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2020 | 14 | 0.180 |
Why?
| | Forkhead Box Protein O3 | 1 | 2020 | 13 | 0.180 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2020 | 57 | 0.170 |
Why?
| | Endothelium | 1 | 2020 | 115 | 0.170 |
Why?
| | Cell Proliferation | 3 | 2017 | 2194 | 0.170 |
Why?
| | Ligands | 1 | 2021 | 569 | 0.170 |
Why?
| | Mice, Inbred C57BL | 5 | 2017 | 4773 | 0.170 |
Why?
| | GTPase-Activating Proteins | 1 | 2019 | 71 | 0.160 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2019 | 56 | 0.160 |
Why?
| | Cell Movement | 2 | 2017 | 867 | 0.160 |
Why?
| | Pulmonary Circulation | 3 | 2009 | 410 | 0.160 |
Why?
| | Adenosine | 1 | 2020 | 203 | 0.160 |
Why?
| | Immune System | 1 | 2019 | 173 | 0.150 |
Why?
| | Leukocytes | 1 | 2019 | 281 | 0.150 |
Why?
| | ets-Domain Protein Elk-1 | 1 | 2017 | 13 | 0.150 |
Why?
| | Smooth Muscle Myosins | 1 | 2017 | 7 | 0.150 |
Why?
| | Xanthine Dehydrogenase | 1 | 2017 | 25 | 0.150 |
Why?
| | Phenotype | 2 | 2017 | 2839 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2019 | 316 | 0.150 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2020 | 374 | 0.150 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2017 | 61 | 0.150 |
Why?
| | Dehydroepiandrosterone | 2 | 2008 | 49 | 0.140 |
Why?
| | Toll-Like Receptor 9 | 1 | 2017 | 30 | 0.140 |
Why?
| | Microfilament Proteins | 1 | 2017 | 126 | 0.140 |
Why?
| | Cigarette Smoking | 1 | 2018 | 80 | 0.140 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2018 | 73 | 0.140 |
Why?
| | Reactive Oxygen Species | 1 | 2019 | 549 | 0.140 |
Why?
| | Heart Ventricles | 1 | 2021 | 722 | 0.140 |
Why?
| | Calcium-Binding Proteins | 1 | 2017 | 203 | 0.130 |
Why?
| | Humans | 13 | 2021 | 115741 | 0.130 |
Why?
| | Oxidative Phosphorylation | 1 | 2016 | 156 | 0.130 |
Why?
| | Inflammation | 2 | 2023 | 2500 | 0.130 |
Why?
| | Cells, Cultured | 3 | 2017 | 3914 | 0.130 |
Why?
| | Nicotine | 1 | 2018 | 266 | 0.130 |
Why?
| | Actins | 1 | 2017 | 383 | 0.130 |
Why?
| | Glycolysis | 1 | 2016 | 224 | 0.130 |
Why?
| | Myocytes, Cardiac | 1 | 2019 | 457 | 0.130 |
Why?
| | Neovascularization, Physiologic | 1 | 2016 | 174 | 0.130 |
Why?
| | Clinical Trials as Topic | 1 | 2019 | 941 | 0.120 |
Why?
| | Fibroblasts | 1 | 2019 | 839 | 0.120 |
Why?
| | Models, Biological | 1 | 2021 | 1646 | 0.120 |
Why?
| | Genotype | 2 | 2017 | 1787 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 2 | 2010 | 790 | 0.120 |
Why?
| | Blotting, Western | 3 | 2012 | 1153 | 0.110 |
Why?
| | Methylcholanthrene | 1 | 2012 | 18 | 0.100 |
Why?
| | Butylated Hydroxytoluene | 1 | 2012 | 32 | 0.100 |
Why?
| | Immunoenzyme Techniques | 1 | 2012 | 193 | 0.100 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2004 | 277 | 0.100 |
Why?
| | Hypertrophy, Left Ventricular | 2 | 2002 | 103 | 0.100 |
Why?
| | Mice, Transgenic | 3 | 2023 | 1970 | 0.090 |
Why?
| | Alcoholism | 1 | 2017 | 717 | 0.090 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2012 | 167 | 0.090 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2012 | 225 | 0.090 |
Why?
| | In Vitro Techniques | 3 | 2007 | 1044 | 0.090 |
Why?
| | Chemoprevention | 1 | 2010 | 88 | 0.090 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2010 | 56 | 0.090 |
Why?
| | Biomarkers | 1 | 2020 | 3471 | 0.080 |
Why?
| | Cytochrome P-450 Enzyme System | 1 | 2010 | 108 | 0.080 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 1098 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2010 | 1870 | 0.080 |
Why?
| | Antioxidants | 1 | 2012 | 533 | 0.080 |
Why?
| | Monocrotaline | 1 | 2008 | 33 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2019 | 3580 | 0.080 |
Why?
| | Molecular Targeted Therapy | 1 | 2010 | 348 | 0.070 |
Why?
| | Guanylate Cyclase | 1 | 2007 | 32 | 0.070 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 206 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2005 | 388 | 0.070 |
Why?
| | Biomarkers, Tumor | 1 | 2012 | 1048 | 0.070 |
Why?
| | Cattle | 2 | 2020 | 935 | 0.060 |
Why?
| | Calcineurin | 2 | 2003 | 84 | 0.060 |
Why?
| | Serotonin | 1 | 2007 | 296 | 0.060 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 195 | 0.060 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2004 | 8 | 0.060 |
Why?
| | Arrestins | 1 | 2004 | 14 | 0.060 |
Why?
| | Male | 12 | 2020 | 56050 | 0.060 |
Why?
| | Angiotensin II | 1 | 2004 | 91 | 0.060 |
Why?
| | Heat Shock Transcription Factors | 1 | 2023 | 17 | 0.060 |
Why?
| | Antibodies, Monoclonal | 1 | 2010 | 1265 | 0.060 |
Why?
| | Adenocarcinoma | 1 | 2010 | 799 | 0.060 |
Why?
| | Aortic Stenosis, Subvalvular | 1 | 2003 | 4 | 0.060 |
Why?
| | Heat-Shock Response | 1 | 2023 | 46 | 0.060 |
Why?
| | Autonomic Nervous System | 1 | 2003 | 70 | 0.050 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 263 | 0.050 |
Why?
| | Phosphorylation | 2 | 2004 | 1571 | 0.050 |
Why?
| | Oxidative Stress | 2 | 2020 | 1093 | 0.050 |
Why?
| | Forkhead Transcription Factors | 1 | 2023 | 171 | 0.050 |
Why?
| | Antineoplastic Agents | 2 | 2010 | 1893 | 0.050 |
Why?
| | MAP Kinase Kinase Kinase 1 | 1 | 2002 | 14 | 0.050 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2023 | 191 | 0.050 |
Why?
| | Enzyme Inhibitors | 2 | 2005 | 757 | 0.050 |
Why?
| | Myocardial Contraction | 1 | 2003 | 315 | 0.050 |
Why?
| | Protein Kinases | 1 | 2004 | 306 | 0.050 |
Why?
| | Heme | 1 | 2021 | 56 | 0.050 |
Why?
| | Calcineurin Inhibitors | 1 | 2001 | 59 | 0.050 |
Why?
| | Cyclosporine | 1 | 2001 | 169 | 0.050 |
Why?
| | Female | 5 | 2017 | 60018 | 0.050 |
Why?
| | Hemolysis | 1 | 2021 | 146 | 0.040 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2023 | 503 | 0.040 |
Why?
| | Extracellular Fluid | 1 | 2020 | 32 | 0.040 |
Why?
| | Neoplasms | 1 | 2013 | 2118 | 0.040 |
Why?
| | Gadolinium | 1 | 2019 | 79 | 0.040 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2020 | 332 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2020 | 400 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2020 | 431 | 0.040 |
Why?
| | Injections | 1 | 2018 | 161 | 0.040 |
Why?
| | Bronchoalveolar Lavage | 1 | 2017 | 89 | 0.040 |
Why?
| | Anemia, Hemolytic | 1 | 2017 | 19 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2020 | 362 | 0.040 |
Why?
| | Receptors, Purinergic | 1 | 2016 | 20 | 0.030 |
Why?
| | Cyclooxygenase 2 | 1 | 2017 | 164 | 0.030 |
Why?
| | Lipid Peroxidation | 1 | 2017 | 138 | 0.030 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2017 | 145 | 0.030 |
Why?
| | Apoptosis | 2 | 2002 | 2377 | 0.030 |
Why?
| | Vasoconstriction | 2 | 2007 | 185 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2017 | 370 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 826 | 0.030 |
Why?
| | Chronic Disease | 2 | 2009 | 1598 | 0.030 |
Why?
| | Atrial Natriuretic Factor | 2 | 2003 | 58 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2017 | 677 | 0.030 |
Why?
| | Hemodynamics | 2 | 2009 | 1024 | 0.030 |
Why?
| | Disease Progression | 1 | 2019 | 2423 | 0.030 |
Why?
| | Rats, Inbred WKY | 1 | 2009 | 32 | 0.020 |
Why?
| | Receptors, Chemokine | 1 | 2009 | 43 | 0.020 |
Why?
| | Dinoprostone | 1 | 2010 | 186 | 0.020 |
Why?
| | Epoprostenol | 1 | 2010 | 133 | 0.020 |
Why?
| | Cadherins | 1 | 2010 | 175 | 0.020 |
Why?
| | Gene Expression Regulation | 2 | 2009 | 2353 | 0.020 |
Why?
| | Cell Adhesion Molecules | 1 | 2009 | 168 | 0.020 |
Why?
| | Endothelin B Receptor Antagonists | 1 | 2007 | 11 | 0.020 |
Why?
| | Chemokines | 1 | 2009 | 214 | 0.020 |
Why?
| | Adenoma | 1 | 2010 | 187 | 0.020 |
Why?
| | Endothelin A Receptor Antagonists | 1 | 2007 | 24 | 0.020 |
Why?
| | Potassium Chloride | 1 | 2007 | 35 | 0.020 |
Why?
| | DNA Primers | 1 | 2009 | 514 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 350 | 0.020 |
Why?
| | Perfusion | 1 | 2007 | 151 | 0.020 |
Why?
| | Soluble Guanylyl Cyclase | 1 | 2007 | 15 | 0.020 |
Why?
| | Amides | 1 | 2007 | 88 | 0.020 |
Why?
| | Cell Division | 1 | 2009 | 759 | 0.020 |
Why?
| | Nitroprusside | 1 | 2007 | 64 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2009 | 746 | 0.020 |
Why?
| | Cyclic GMP | 1 | 2007 | 80 | 0.020 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 2007 | 44 | 0.020 |
Why?
| | Pneumonectomy | 1 | 2008 | 126 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 274 | 0.020 |
Why?
| | Aorta, Thoracic | 1 | 2009 | 262 | 0.020 |
Why?
| | Monocytes | 1 | 2009 | 507 | 0.020 |
Why?
| | Acetylcholine | 1 | 2007 | 180 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2007 | 185 | 0.020 |
Why?
| | Random Allocation | 1 | 2007 | 337 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2009 | 438 | 0.020 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2005 | 27 | 0.020 |
Why?
| | Peptides, Cyclic | 1 | 2007 | 262 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2005 | 376 | 0.020 |
Why?
| | Vasodilator Agents | 1 | 2007 | 308 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 724 | 0.020 |
Why?
| | beta-Arrestin 2 | 1 | 2004 | 4 | 0.020 |
Why?
| | beta-Arrestins | 1 | 2004 | 11 | 0.020 |
Why?
| | beta-Arrestin 1 | 1 | 2004 | 6 | 0.020 |
Why?
| | Time Factors | 2 | 2008 | 6171 | 0.020 |
Why?
| | Clathrin | 1 | 2004 | 27 | 0.010 |
Why?
| | Genes, Dominant | 1 | 2004 | 93 | 0.010 |
Why?
| | CHO Cells | 1 | 2004 | 140 | 0.010 |
Why?
| | Pyridines | 1 | 2007 | 425 | 0.010 |
Why?
| | COS Cells | 1 | 2004 | 175 | 0.010 |
Why?
| | Cricetinae | 1 | 2004 | 260 | 0.010 |
Why?
| | Autonomic Denervation | 1 | 2003 | 2 | 0.010 |
Why?
| | Estradiol | 1 | 2007 | 452 | 0.010 |
Why?
| | Testosterone | 1 | 2007 | 337 | 0.010 |
Why?
| | Endocytosis | 1 | 2004 | 152 | 0.010 |
Why?
| | Aorta, Abdominal | 1 | 2003 | 40 | 0.010 |
Why?
| | Microscopy, Confocal | 1 | 2004 | 299 | 0.010 |
Why?
| | Electrophysiology | 1 | 2003 | 202 | 0.010 |
Why?
| | Immunoblotting | 1 | 2003 | 281 | 0.010 |
Why?
| | Protein Transport | 1 | 2004 | 400 | 0.010 |
Why?
| | Potassium Channels | 1 | 2003 | 121 | 0.010 |
Why?
| | Green Fluorescent Proteins | 1 | 2004 | 377 | 0.010 |
Why?
| | Altitude | 1 | 2005 | 409 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2004 | 804 | 0.010 |
Why?
| | Nitric Oxide | 1 | 2007 | 832 | 0.010 |
Why?
| | Models, Animal | 1 | 2003 | 350 | 0.010 |
Why?
| | Calcium Signaling | 1 | 2003 | 211 | 0.010 |
Why?
| | Ligation | 1 | 2001 | 77 | 0.010 |
Why?
| | Cell Size | 1 | 2001 | 81 | 0.010 |
Why?
| | Injections, Subcutaneous | 1 | 2001 | 137 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 2001 | 399 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2129 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2004 | 2000 | 0.010 |
Why?
| | Calcium | 1 | 2005 | 1103 | 0.010 |
Why?
| | Iron | 1 | 2001 | 235 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 2002 | 446 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 2790 | 0.010 |
Why?
| | Fibrosis | 1 | 2001 | 457 | 0.010 |
Why?
| | Aorta | 1 | 2001 | 397 | 0.010 |
Why?
| | Kidney | 1 | 2004 | 1207 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 27069 | 0.010 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2002 | 1137 | 0.010 |
Why?
| | Gene Expression | 1 | 2002 | 1436 | 0.010 |
Why?
| | Adult | 1 | 2017 | 30789 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2003 | 2574 | 0.010 |
Why?
|
|
Karoor's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|